Is GSGTF or RYLD a better dividend investment in 2026?

GSGTF currently yields 1052.08% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: GSGTF offers higher current income.

What is the dividend yield difference between GSGTF and RYLD?

GSGTF has a forward dividend yield of 1052.08% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 1039.94 percentage points.

Home › Compare › GSGTF vs RYLD

GSGTF vs RYLD: Dividend Comparison 2026

GSGTF yields 1052.08% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GSGTF wins by $29376466.50M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GSGTF

● Live price

1052.08%

Share price

$0.19

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29376466.55M

Annual income

$24,748,961,707,406.69

Full GSGTF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — GSGTF vs RYLD

📍 GSGTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GSGTF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GSGTF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GSGTF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GSGTF

Annual income on $10K today (after 15% tax)

$89,426.62/yr

After 10yr DRIP, annual income (after tax)

$21,036,617,451,295.69/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, GSGTF beats the other by $21,036,617,449,096.44/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GSGTF + RYLD for your $10,000?

GSGTF: 50%RYLD: 50%

100% RYLD50/50100% GSGTF

Portfolio after 10yr

$14688233.30M

Annual income

$12,374,480,854,997.02/yr

Blended yield

84.25%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GSGTF buys

RYLD buys

No recent congressional trades found for GSGTF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGSGTFRYLD

Forward yield	1052.08% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$29376466.55M ✓	$44.5K
Annual income after 10y	$24,748,961,707,406.69 ✓	$2,587.35
Total dividends collected	$29025351.72M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: GSGTF vs RYLD ($10,000, DRIP)

Year	GSGTF Portfolio	GSGTF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$115,908	$105,207.79	$11,914	$1,213.65	+$104.0K → GSGTF
2	$1,263,685	$1,139,663.68	$14,099	$1,351.30	+$1.25M → GSGTF
3	$12,964,467	$11,612,324.37	$16,580	$1,494.55	+$12.95M → GSGTF
4	$125,211,982	$111,340,001.64	$19,384	$1,642.61	+$125.19M → GSGTF
5	$1,138,959,685	$1,004,982,865.01	$22,535	$1,794.70	+$1138.94M → GSGTF
6	$9,762,216,739	$8,543,529,875.74	$26,063	$1,950.00	+$9762.19M → GSGTF
7	$78,882,996,544	$68,437,424,632.64	$29,995	$2,107.69	+$78882.97M → GSGTF
8	$601,231,379,017	$516,826,572,714.96	$34,361	$2,266.99	+$601231.34M → GSGTF
9	$4,324,770,879,470	$3,681,453,303,922.24	$39,194	$2,427.12	+$4324770.84M → GSGTF
10	$29,376,466,548,439	$24,748,961,707,406.69	$44,525	$2,587.35	+$29376466.50M → GSGTF

GSGTF vs RYLD: Complete Analysis 2026

GSGTF — Stock

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company also develops products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France.

Full GSGTF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this GSGTF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GSGTF vs SCHD GSGTF vs JEPI GSGTF vs O GSGTF vs KO GSGTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.